BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29949149)

  • 1. Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect.
    Shen Y; Zhang ZB; Wu SD; Wu XB; Li J
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3749-3754. PubMed ID: 29949149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
    Vocka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
    Cancer Biomark; 2018; 21(4):869-874. PubMed ID: 29400662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 as biomarker in uterine sarcomas.
    Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
    Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity.
    Lee ES; Kim SH; Kim HJ; Kim KH; Lee BS; Ku BJ
    Gut Liver; 2017 Mar; 11(2):276-282. PubMed ID: 27728964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between levels of serum growth differentiation factor-15 and acute coronary syndrome].
    Zheng LB; Guo YH; Yu HY; Mi L; Wang YP; Gao W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):250-4. PubMed ID: 21503121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
    Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
    Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
    Engerud H; Hope K; Berg HF; Fasmer KE; Tangen IL; Haldorsen IS; Trovik J; Krakstad C
    PLoS One; 2019; 14(1):e0210585. PubMed ID: 30645608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
    Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
    Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
    Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps.
    Sari K; Gencer ZK; Ede H; Gocmen AY; Kantekin Y
    Auris Nasus Larynx; 2016 Oct; 43(5):529-36. PubMed ID: 26795264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.
    Gamal SM; Elgengehy FT; Kamal A; El Bakry SA; Shabaan E; Elgendy A; Bassyouni IH
    Immunol Invest; 2017 Oct; 46(7):703-713. PubMed ID: 28872977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population.
    Dong X; Nao J
    Int J Neurosci; 2019 Dec; 129(12):1247-1255. PubMed ID: 31446824
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.
    Altena R; Fehrmann RS; Boer H; de Vries EG; Meijer C; Gietema JA
    PLoS One; 2015; 10(1):e0115372. PubMed ID: 25590623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
    Traeger L; Ellermann I; Wiethoff H; Ihbe J; Gallitz I; Eveslage M; Moritz R; Herrmann E; Schrader AJ; Steinbicker AU
    BMC Cancer; 2019 Jan; 19(1):74. PubMed ID: 30646851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
    Bock AJ; Stavnes HT; Kempf T; Tropè CG; Berner A; Davidson B; Staff AC
    Int J Gynecol Cancer; 2010 Dec; 20(9):1448-55. PubMed ID: 21336029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma.
    Weide B; Schäfer T; Martens A; Kuzkina A; Uder L; Noor S; Garbe C; Harter PN; Mittelbronn M; Wischhusen J
    J Invest Dermatol; 2016 Dec; 136(12):2444-2452. PubMed ID: 27705749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].
    Li H; Gao F; Xue Y; Qian Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):387-90. PubMed ID: 24670455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.